BR112013020005A8 - peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica - Google Patents

peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica

Info

Publication number
BR112013020005A8
BR112013020005A8 BR112013020005A BR112013020005A BR112013020005A8 BR 112013020005 A8 BR112013020005 A8 BR 112013020005A8 BR 112013020005 A BR112013020005 A BR 112013020005A BR 112013020005 A BR112013020005 A BR 112013020005A BR 112013020005 A8 BR112013020005 A8 BR 112013020005A8
Authority
BR
Brazil
Prior art keywords
stereoisomers
cosmetic
acceptable salts
pharmaceutically
pharmaceutically acceptable
Prior art date
Application number
BR112013020005A
Other languages
English (en)
Other versions
BR112013020005A2 (pt
Inventor
Vicente Ferrer Montiel Antonio
Maria García Antón José
Almiñana Domenech Nuria
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Publication of BR112013020005A2 publication Critical patent/BR112013020005A2/pt
Publication of BR112013020005A8 publication Critical patent/BR112013020005A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica trata-se de peptídeos de fórmula geral (i): r~1~ - w~n~ - x~m~ -aa~1~ - aa~2~ - aa~3~ - aa~4~ - aa~5~ - aa~6~ - y~p~ - z~q~ - r~2~ (i) seus estereoisômeros, misturadas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis, um processo de preparação, composições cosméticas ou farmacêuticas que contêm os mesmos e seu uso para o tratamento e/ou cuidade de distúrbios e/ou doenças da pele e/ou membranas mucosas.
BR112013020005A 2011-03-25 2012-03-23 peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica BR112013020005A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161467643P 2011-03-25 2011-03-25
ES201130441A ES2397890B1 (es) 2011-03-25 2011-03-25 Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
PCT/EP2012/055250 WO2012130771A1 (en) 2011-03-25 2012-03-23 Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions

Publications (2)

Publication Number Publication Date
BR112013020005A2 BR112013020005A2 (pt) 2017-10-31
BR112013020005A8 true BR112013020005A8 (pt) 2018-01-09

Family

ID=46929507

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013020005A BR112013020005A8 (pt) 2011-03-25 2012-03-23 peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica

Country Status (9)

Country Link
US (1) US9067967B2 (pt)
EP (1) EP2651963B1 (pt)
JP (1) JP6075650B2 (pt)
KR (1) KR101988675B1 (pt)
CN (1) CN103314005B (pt)
AU (1) AU2012234366B2 (pt)
BR (1) BR112013020005A8 (pt)
ES (2) ES2397890B1 (pt)
WO (1) WO2012130771A1 (pt)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389663B2 (en) 2011-04-01 2022-07-19 Bioregentech, Inc. Laser assisted wound healing protocol and system
US11730760B2 (en) 2011-04-01 2023-08-22 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
EP2986250A4 (en) * 2013-04-16 2017-03-22 Molecular Systems Ltd. Laser assisted periodontium and osseus regeneration protocol
US20160000858A1 (en) * 2014-07-07 2016-01-07 Gojo Industries, Inc. Compositions and methods for mitigating skin irritation and enhancing skin barrier function
CN107111234B (zh) * 2014-10-21 2020-08-04 日产化学工业株式会社 抗蚀剂下层膜形成用组合物
CR20170179A (es) 2014-10-31 2017-07-20 Lubrizol Advanced Mat Inc Película de poliuretano termoplástico para la liberación de agentes activos a superficies de piel
CN104622779A (zh) * 2015-01-08 2015-05-20 上海圣婕化妆品有限公司 一种多胜肽抗衰老修复面膜精华液及其制备方法
CN104523449A (zh) * 2015-01-08 2015-04-22 上海圣婕化妆品有限公司 一种抗衰老多胜肽复合物及其应用
WO2016138294A1 (en) * 2015-02-25 2016-09-01 The Regents Of The University Of California Hesperidin-containing compositions and methods for treatment of skin disorders
EP3277255A1 (en) 2015-03-31 2018-02-07 GOJO Industries, Inc. Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function
EP3117830A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Antibacterial peptides, and uses thereof
EP3118215A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Anti-inflammatory peptides, and uses thereof
CN114835784A (zh) 2015-07-16 2022-08-02 努里塔斯有限公司 抗炎肽及其用途
EP3118216A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Cellular growth and proliferation promoting peptides, and uses thereof
EP3117831A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Peptides for use in promoting transport of glucose into skeletal muscle
CN104997693A (zh) * 2015-07-31 2015-10-28 魏善众 植物甾醇酯化妆品
CN105039030A (zh) * 2015-08-06 2015-11-11 吴敏 一种预防妊娠纹的香皂及其制备方法
CA3003871A1 (en) 2015-11-05 2017-05-11 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
KR101686399B1 (ko) * 2015-11-26 2016-12-15 코스맥스 유에스에이, 코퍼레이션 항노화용 화장료 조성물
WO2017100421A1 (en) * 2015-12-10 2017-06-15 Lubrizol Advanced Materials, Inc. Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes
KR20180114911A (ko) 2016-02-04 2018-10-19 앨러스틴 스킨케어, 인크. 침습 및 비침습 시술적 피부 관리를 위한 조성물 및 방법
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
US9872523B2 (en) * 2016-05-13 2018-01-23 Elvis Salkovic Piece of clothing for supporting sleep
WO2018014936A1 (en) * 2016-07-18 2018-01-25 Nuritas Limited Topical compositions
WO2018089954A1 (en) 2016-11-10 2018-05-17 BioRegentech Laser assisted wound healing protocol and system
US11654293B2 (en) 2016-11-10 2023-05-23 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
EP3329930A1 (en) 2016-12-05 2018-06-06 Nuritas Limited Pharmaceuctical compositions
EP3548058B1 (en) * 2016-12-05 2022-06-22 Nuritas Limited Compositions comprising peptide wkdeagkplvk
EP3329905A1 (en) * 2016-12-05 2018-06-06 Nuritas Limited Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
CN106667788A (zh) * 2017-02-08 2017-05-17 广东科玮生物技术股份有限公司 一种含生长因子的面膜液及干式面膜
KR102087123B1 (ko) 2017-04-21 2020-03-10 유씨엘 주식회사 펩타이드와 해조류 추출물을 함유하는 나노에멀젼 및 그를 이용한 화장료 조성물
WO2019008452A1 (en) * 2017-07-04 2019-01-10 Lubrizol Advanced Materials, Inc. COMPOUNDS USEFUL IN THE TREATMENT AND / OR CARE OF THE SKIN, HAIR, NAILS AND / OR MUCOUS MEMBRANES
KR20200036007A (ko) 2017-08-03 2020-04-06 앨러스틴 스킨케어, 인크. 피부 이완 및 신체 윤곽의 개선을 위한 조성물 및 방법
CN107365355B (zh) * 2017-08-07 2020-06-26 温州千瑞生物科技有限公司 抗皱纹的肽以及包含其的化妆品
CN107778349B (zh) * 2017-11-29 2021-05-04 陕西慧康生物科技有限责任公司 一种合成ghk醋酸盐的方法
KR102038366B1 (ko) * 2018-05-29 2019-10-30 주식회사 조인앤믹스 여드름 피부 개선용 화장료 조성물
US10980851B2 (en) * 2018-06-08 2021-04-20 The Procter & Gamble Company Topical skincare compositions comprising Centella asiatica selected triterpenes
WO2019238962A1 (en) 2018-06-14 2019-12-19 University College Cork - National University Of Ireland, Cork Peptide for disease treatment
CN110652578A (zh) * 2018-06-29 2020-01-07 重庆合钰成贸易有限公司 女性舒柔养护凝胶及其制备方法
WO2020009548A1 (ko) * 2018-07-06 2020-01-09 애니젠 주식회사 펩타이드 복합체를 유효성분으로 함유하는 미세먼지 제거 또는 흡착용 화장료 조성물
US11103455B2 (en) 2018-08-02 2021-08-31 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
CN109010113B (zh) * 2018-08-28 2021-08-17 高宝化妆品（中国）有限公司 一种修复敏感肌肤的组合物及其应用
CN109431914B (zh) * 2018-12-27 2020-07-07 湖南御家化妆品制造有限公司 头皮养护组合物及其应用
BR112021022242A2 (pt) * 2019-05-08 2022-01-18 Alastin Skincare Inc Composições e métodos para melhorar hematoma e para rejuvenescimento da pele
CN114007583A (zh) * 2019-06-28 2022-02-01 欧莱雅 抗衰老组合物和含有抗衰老组合物的皮肤面膜
EP3783012A1 (en) 2019-08-20 2021-02-24 Nuritas Limited An antimicrobial peptide
KR20220103695A (ko) 2019-08-20 2022-07-22 뉴리타스 리미티드 근육 위축을 치료하기 위한 펩티드
AU2020370733A1 (en) 2019-10-22 2022-05-05 Nuritas Limited Treatment of non-alcoholic fatty liver disease
US20230000759A1 (en) * 2019-12-30 2023-01-05 Rodan & Fields, Llc Ppar agonist complex and methods of use
EP3862014A1 (en) 2020-02-07 2021-08-11 Nuritas Limited Treatment of panx1 associated diseases
CN111909243B (zh) * 2020-08-04 2022-01-18 立康荣健(北京)生物医药科技有限公司 一种抗菌肽和抗菌止痒药物组合物及应用
US20230320967A1 (en) * 2020-09-11 2023-10-12 Chemyunion Ltda. Composition, use of the composition, cosmetic method for modulating the production of sebum
BR112023012422A2 (pt) 2021-01-24 2023-12-12 Michael David Forrest Inibidores da atp sintase - usos cosmético e terapêutico
AU2022259536A1 (en) 2021-04-14 2023-11-09 University College Cork - National University Of Ireland, Cork Treatment of cerebrovascular events and neurological disorders
EP4322984A1 (en) 2021-04-14 2024-02-21 University College Cork-National University of Ireland Cork Psg1 for use in the treatment of osteoarthritis
CN113750216B (zh) * 2021-10-22 2022-10-25 北美生命科学(上海)有限公司 一种抗衰老的化妆品或药物
CN114315968B (zh) * 2021-12-31 2022-10-18 深圳市维琪医药研发有限公司 一种九肽及其美容组合物或药用组合物和用途
CN115192471B (zh) * 2022-07-13 2023-07-18 海南省麦吉丽生物科技有限公司 一种可以改善皮肤弹性的纳米乳凝胶、化妆品组合物及其制备和应用
WO2024078729A1 (en) 2022-10-14 2024-04-18 University College Cork - National University Of Ireland, Cork Placenta expressed proteins for use in the treatment of tendon injury

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695035A1 (fr) 1992-08-25 1994-03-04 Lvmh Rech Gie Utilisation d'un ecdystéroïde pour la préparation de compositions cosmétiques ou dermatologiques destinées notamment à renforcer la fonction protectrice de la peau, et compositions ainsi obtenues.
FR2801504B1 (fr) 1999-11-26 2002-02-15 Lvmh Rech Extrait d'ajuga turkestanica et ses applications cosmetiques
FR2831058B1 (fr) 2001-10-18 2004-01-16 Jean Noel Thorel Composition cosmetique hydratante comprenant des aquaporines
CA2465123A1 (en) * 2001-10-30 2003-05-08 Pentapharm Ag Dermopharmaceutically and cosmetically active oligopeptides
JP2004168732A (ja) 2002-11-22 2004-06-17 Kanebo Ltd 活性酸素消去剤、ヒアルロン酸合成促進・分解抑制剤およびアクアポリン合成促進剤
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
ES2293753B1 (es) * 2004-04-28 2009-03-16 Lipotec, S.A. Uso de peptidos xikvav en preparacion de composiciones cosmeticas para mejorar la firmeza de la piel mediante el aumento de la adhesion celular.
JP2005343882A (ja) 2004-06-07 2005-12-15 Kanebo Cosmetics Inc ヒアルロン酸産生促進剤、アクアポリン合成促進剤、及び皮膚外用剤組成物
JP2006290873A (ja) 2005-03-14 2006-10-26 Rohto Pharmaceut Co Ltd アクアポリン発現促進剤
WO2006113681A2 (en) 2005-04-15 2006-10-26 Human Matrix Sciences, Llc Plant-derived elastin binding protein ligands and methods of using the same
CN101217999A (zh) 2005-07-08 2008-07-09 宝洁公司 用于哺乳动物皮肤和毛发美化的个人护理组合物及方法
FR2889949B1 (fr) 2005-08-26 2014-01-10 Jean Noel Thorel Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus
US20090130223A1 (en) 2006-04-27 2009-05-21 Ute Breitenbach Cosmetic preparation with aquaporin stimulators and the use thereof
FR2903015B1 (fr) 2006-06-30 2012-07-20 Courtage Et De Diffusion Codif Internat Soc D Utilisation d'au moins un extrait d'une algue brune et/ou d'une plante halophyte pour la realisation de compositions cosmetiques.
KR20080024868A (ko) 2006-09-15 2008-03-19 전남대학교산학협력단 수분채널단백질인 아쿠아포린 및 이를 조절하는 여성의 질윤활제
DE102007024384A1 (de) 2007-05-23 2008-11-27 Henkel Ag & Co. Kgaa Kosmetische und dermatologische Zusammensetzungen gegen trockene Haut
FR2925501B1 (fr) 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925500B1 (fr) * 2007-12-21 2011-05-06 Vincience Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
ES2330291B1 (es) * 2008-02-29 2010-10-18 Lipotec Sa Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
WO2009106934A1 (en) 2008-02-29 2009-09-03 Chemyunion Química Ltda Angico-branco (piptadenia colubrina) extracts for use in cosmetic and dermatological formulations
FR2928090B1 (fr) 2008-03-03 2014-10-10 Lvmh Rech Utilisation d'un extrait de l'orchidee vanda coerulea comme agent hydratant de la peau
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
ES2349972B1 (es) 2009-02-16 2011-11-24 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
EP2419437A1 (en) * 2009-04-17 2012-02-22 Lipotec, S.A. Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
FR2954697B1 (fr) * 2009-12-24 2016-11-04 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un extrait de caroube en tant qu'agent actif activateur de l'expression des aquaporines

Also Published As

Publication number Publication date
ES2397890A1 (es) 2013-03-12
WO2012130771A1 (en) 2012-10-04
AU2012234366B2 (en) 2017-04-13
JP6075650B2 (ja) 2017-02-08
AU2012234366A1 (en) 2013-07-18
EP2651963B1 (en) 2016-03-23
KR20140043727A (ko) 2014-04-10
US9067967B2 (en) 2015-06-30
CN103314005B (zh) 2016-08-10
CN103314005A (zh) 2013-09-18
ES2572260T3 (es) 2016-05-31
ES2397890B1 (es) 2014-02-07
KR101988675B1 (ko) 2019-06-12
EP2651963A1 (en) 2013-10-23
JP2014510090A (ja) 2014-04-24
US20140120141A1 (en) 2014-05-01
BR112013020005A2 (pt) 2017-10-31

Similar Documents

Publication Publication Date Title
BR112013020005A2 (pt) peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica
BRPI0913831B8 (pt) peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis, processo para a preparação de um peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica
BR112018011643A2 (pt) composto, composição cosmética ou farmacêutica, uso de um composto, e, método para tratamento e/ou cuidado não terapêutico e cosmético da pele, cabelo, unhas e/ou membranas mucosas.
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
MX2011010859A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
TW201129368A (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
BR112015012565A2 (pt) composto, composição cosmética ou farmacêutica, e, uso de um composto
BRPI0906064B8 (pt) peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i)
BR112015018252A2 (pt) composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit
BR112014028633A8 (pt) tratamento de amd usando sflt-1 de aav
ES2397889A1 (es) PÉPTIDOS MODULADORES DE PGC-1Alfa.
BR112014009851A2 (pt) moduladores de receptor de nmda e usos dos mesmos
BR112015025961A2 (pt) composto, composição cosmética ou farmacêutica, e, uso de um composto
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BRPI0513819A (pt) inibidores de hsp90
BR112015017997A8 (pt) amidas de quinolina e quinoxalina como moduladores de canais de sódio, composição farmacêutica que as compreende e uso
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
BR112012029959A2 (pt) compostos de carbamato de mentila como ativos para clareamento de pele e/ou cabelo
BR112013031510A2 (pt) [1,3]oxazinas
ECSP045140A (es) Formulaciones farmacéuticas derivadas del platino
BRPI0519280A2 (pt) composto, composiÇço farmacÊutica e uso de um composto
BR112014015482A8 (pt) compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática
MX356343B (es) Compuestos que inhiben la exocitosis neuronal (ii).
BR112015025804A2 (pt) derivados de glutarimida, uso dos mesmos, composição farmacêutica com base neles e métodos para a produção de derivados de glutarimida

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2559 DE 2020-01-21